Global manufacturing portfolio leads innovation at AIM Congress 2025
The portfolio delivered deep insights into the transformation of manufacturing ecosystems, product innovation, operational efficiency, and sustainability. Discussions highlighted the industry's commitment to minimizing manual processes, optimizing resource utilization, ensuring worker safety, and boosting productivity and competitiveness.
A standout highlight of the portfolio was the focus on the pharmaceutical industry as a pioneering force of innovation. By embracing smart manufacturing, data analytics, automation, and technologies from the Fifth Industrial Revolution, pharmaceutical companies are accelerating research and development, improving product quality, reducing waste, and meeting the growing demand for affordable, sustainable medicines.
Moreover, advanced technologies like artificial intelligence and the Internet of Things have proven essential in enhancing supply chain resilience and global health security, ensuring rapid and efficient responses to future health challenges.
The tremendous success of the Global Manufacturing portfolio was made possible thanks to the invaluable support of our esteemed partners: Julphar (Lead Partner), Modern Pharmacy (Diamond Partner), Global Pharma LLC (Diamond Package), Quest Vitamin Middle East (Associate Partner), MSD (Silver Partner), Life Pharma (Gold partner package), ADMD (Silver Partner), Vieco (Silver Partner), J&J (, Novartis (Diamond Partner), Biogen (Associate Partner), Servier (Silver Partner), Tabuk Pharmaceuticals (Associate Partner), City Pharmacy (Silver Partner), Gulf Drug (Silver Partner), Hikma (Silver Partner), Safe care/Pure Pharma(Silver Partner), and PHRMAG (Round Table partner).
showcased their latest innovations and advanced technological solutions in smart manufacturing, automation, and data analytics. Their booths witnessed significant visitor engagement, with attendees showing great interest in the displayed technologies, reflecting the vital role these companies play in driving innovation and promoting sustainability in the pharmaceutical industry.
The support of these partners has embodied a true model of collaboration and innovation, reinforcing the position of the Global Manufacturing Hub as a pioneering platform for advancing digital transformation and promoting sustainable practices in the pharmaceutical industry within the United Arab Emirates.
These active partnerships have contributed to accelerating the development of the industrial sector, while emphasizing the critical role of the pharmaceutical industry in supporting national economies and strengthening global health security.
In this context, the pivotal role of the Emirates Drug Establishment (EDE) has emerged clearly, as it coordinated efforts among stakeholders and supported initiatives aimed at developing the regulatory and legislative infrastructure — positioning the UAE as a regional hub for pharmaceutical manufacturing.
This strategic collaboration also marked an important step toward growing the pharmaceutical sector and creating an investment-friendly local environment that fosters advanced solutions to enhance quality of life.
AIM Congress 2025 looks forward to building on this success, continuing to drive the global conversation on industrial innovation, sustainability, and resilience for years to come.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
a day ago
- Zawya
UAE: Julphar turns into profitability in H1-25 backed by operations in Egypt
Gulf Pharmaceutical Industries (Julphar) swung to profitability at AED 158.20 million in the first half (H1) of 2025, against net losses of AED 2.40 million in H1-24. Basic and diluted earnings per share stood at 13.70 fils as of 30 June 2025, compared to a loss per share of 0.10 fils in H1-24, according to the financial results. The company registered AED 707.30 million in revenues from contracts with customers in the first six months (6M) of 2025, an annual increase of 4.70% from AED 675.80 million. Results for Q2 In the second quarter (Q2) of 2025, Julphar delivered net profits worth AED 17.10 million, versus a net loss of AED 4 million in Q2-24. Revenues from contracts with customers rose to AED 348.10 million in Q2-25 from AED 339 million in the corresponding period last year. Basic and diluted EPS hit 1.50 fils in Q2-25, against a loss per share of 0.30 fils in April-June 2024. Despite Q2-25's geopolitical disturbance, the ADX-listed company navigated safely and capitalized on opportunities in key markets, including Egypt, where there was relatively good availability of foreign currency. All Rights Reserved - Mubasher Info © 2005 - 2025 Provided by SyndiGate Media Inc. (
Fintech News ME
a day ago
- Fintech News ME
UAE Proptech Market Set to Triple by 2030 Amid Digital Transformation
The rapid growth of the proptech market holds significant importance for the UAE as it continues to position itself as a global hub for innovation, real estate, and smart urban living. By integrating advanced technologies such as AI, blockchain, the Internet of Things (IoT), as well as virtual reality (VR) and augmented reality (AR), the country is driving greater efficiency, transparency, and customer experience across the real estate sector. According to Construction Week Online, the UAE's proptech sector, valued at AED 2.24 billion in 2024, is projected to almost triple to AED 5.69 billion by 2030, achieving a compound annual growth rate (CAGR) of 17.49%, based on data from Research and Markets. This expansion is largely fuelled by the adoption of technologies that streamline processes in property development, management, transactions, and investments, while also helping to reduce overall costs. In particular, the integration of VR and AR into the local construction industry is enabling smarter, faster, and more efficient project delivery. These tools improve design precision, enhance collaboration, and minimise errors, qualities that are essential for the UAE's fast-paced, high-value developments. As the nation advances its digital transformation agenda, VR and AR are proving to be competitive advantages, boosting productivity, safety, and client engagement. Lifesize Plans Dubai, an Australian-based global leader in life-sized architectural projections, has closely followed the steady rise of both the proptech and construction sectors in the UAE before entering the market in 2023. The company offers a tactile visualisation solution that transforms architectural blueprints into true 1:1 scale projections during the pre-construction stage, enhancing decision-making and certainty, an approach well-suited to the UAE's rapid, high-value development landscape. Georges Calas, CEO of Lifesize Plans Dubai, said: 'From immersive Virtual Reality (VR) and Augmented Reality (AR) walkthroughs to AI-driven analytics, these new technologies are redefining how real estate is bought, sold, and built in the UAE. As the country continues to push the boundaries of innovation and prove to be one of the top investment options for expatriates from all over the world, proptech is quickly becoming a cornerstone of the market's long-term resilience and global competitiveness.' With the UAE steadfast in its goal of becoming a global leader in smart, sustainable development, the role of proptech is set to grow further. From optimising construction workflows to enhancing customer engagement and improving investment decision-making, supported by strong government initiatives and investor confidence, the sector is reshaping the nation's real estate landscape.
Zawya
2 days ago
- Zawya
Julphar achieves $193mln in net revenues for H1/25
RAS AL KHAIMAH: Gulf Pharmaceutical Industries "Julphar" has announced its financial results for the second quarter and first half of the year, showing steady revenue growth, an expansion in operating profits, and an improvement in its financial position. In the first half of 2025, Julphar achieved net revenues of AED707.3 million, a growth of 4.7% (5.8% at constant prices). Gross profit increased to AED298 million, a growth of 12.8%. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew by 27.9% to AED91.6 million, with the profit margin increasing from 10.6% to 13.0%. Net profit also rose from AED7.3 million to AED38.6 million, while total net profit reached AED158.2 million, including an exceptional capital gain of AED118.7 million from the sale of Zahrat Al Rawda Pharmacies Company. Sheikh Saqr bin Humaid bin Abdullah Al Qasimi, Chairman of the Board of Directors of Julphar, stated, "Julphar's performance in the first six months of 2025 represents a pivotal step forward, with strong revenue growth and continuous progress in our strategic priorities. These results reflect our commitment to operational excellence and our teams' ability to achieve ambitious goals. With the launch of new products and market expansion, we are solidifying our position as a leading healthcare partner in the Gulf and beyond."
